Literature for JO146 (S01.480 inhibitor)

(Topics flags: I Inhibitor, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

2019
1. Agbowuro,A.A., Hwang,J., Peel,E., Mazraani,R., Springwald,A., Marsh,J.W., McCaughey,L., Gamble,A.B., Huston,W.M. and Tyndall,J.D.A.
   Structure-activity analysis of peptidic Chlamydia HtrA inhibitors
   Bioorg Med Chem27, 4185-4199. PubMed  Europe PubMed DOI  I
2015
2. Ong,V.A., Lawrence,A., Timms,P., Vodstrcil,L.A., Tabrizi,S.N., Beagley,K.W., Allan,J.A., Hocking,J.S. and Huston,W.M.
   In vitro susceptibility of recent Chlamydia trachomatis clinical isolates to the CtHtrA inhibitor JO146
   Microbes Infect17, 738-744. PubMed  Europe PubMed DOI  U  I
2013
3. Gloeckl,S., Ong,V.A., Patel,P., Tyndall,J.D., Timms,P., Beagley,K.W., Allan,J.A., Armitage,C.W., Turnbull,L., Whitchurch,C.B., Merdanovic,M., Ehrmann,M., Powers,J.C., Oleksyszyn,J., Verdoes,M., Bogyo,M. and Huston,W.M.
   Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis
   Mol Microbiol89, 676-689. PubMed  Europe PubMed DOI  I